2 min listen
FDA Approves Aducanumab — A Controversial Drug For Alzheimer's
FromShort Wave
ratings:
Length:
12 minutes
Released:
Jun 25, 2021
Format:
Podcast episode
Description
The FDA has approved a new drug for Alzheimer's. But a lot of experts are skeptical about whether the drug works. Rhitu Chatterjee talks with science correspondent Jon Hamilton about the controversial drug aducanumab and why the U.S. Food and Drug Administration approved it. For more of Jon's reporting, read "For Those Facing Alzheimer's, A Controversial Drug Offers Hope."You can email Short Wave at ShortWave@NPR.org.
Released:
Jun 25, 2021
Format:
Podcast episode
Titles in the series (100)
Introducing Short Wave: Short Wave, NPR's new daily science podcast, starts October 15th. Join host Maddie Sofia, Monday through Friday. Subscribe now. by Short Wave